Healthcare provider profile · identity verified

Krysta Brown, DO

Internal Medicine · WEST READING, PA · NPI 1033539994

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	579	160
Amlodipine Besylate	Amlodipine Besylate	403	123
Lisinopril	Lisinopril	316	86
Omeprazole	Omeprazole	261	70
Levothyroxine Sodium	Levothyroxine Sodium	250	68
Losartan Potassium	Losartan Potassium	223	73
Metformin Hcl	Metformin Hcl	219	64
Pantoprazole Sodium	Pantoprazole Sodium	208	64
Rosuvastatin Calcium	Rosuvastatin Calcium	196	58
Gabapentin	Gabapentin	157	44
Fluticasone Propionate	Fluticasone Propionate	152	50
Carvedilol	Carvedilol	128	30
Jardiance	Empagliflozin	124	30
Hydrochlorothiazide	Hydrochlorothiazide	121	40
Duloxetine Hcl	Duloxetine Hcl	119	35
Ozempic	Semaglutide	119	25
Metoprolol Tartrate	Metoprolol Tartrate	99	28
Furosemide	Furosemide	95	33
Albuterol Sulfate Hfa	Albuterol Sulfate	92	36
Sertraline Hcl	Sertraline Hcl	83	24
Metoprolol Succinate	Metoprolol Succinate	82	29
Clopidogrel	Clopidogrel Bisulfate	81	20
Eliquis	Apixaban	77	24
Tamsulosin Hcl	Tamsulosin Hcl	68	18
Alendronate Sodium	Alendronate Sodium	66	11
Famotidine	Famotidine	61	16
Potassium Chloride	Potassium Chloride	61	22
Simvastatin	Simvastatin	60	17
Ventolin Hfa	Albuterol Sulfate	58	13
Montelukast Sodium	Montelukast Sodium	53	16
Metformin Hcl Er	Metformin Hcl	51	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	51	suppressed
Breo Ellipta	Fluticasone/Vilanterol	47	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	19
Tramadol Hcl	Tramadol Hcl	47	suppressed
Pravastatin Sodium	Pravastatin Sodium	45	14
Spironolactone	Spironolactone	45	13
Quetiapine Fumarate	Quetiapine Fumarate	44	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	43	14
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Allopurinol	Allopurinol	42	12
Trazodone Hcl	Trazodone Hcl	40	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	13
Donepezil Hcl	Donepezil Hcl	39	suppressed
Trulicity	Dulaglutide	39	suppressed
Bupropion Xl	Bupropion Hcl	38	11
Buspirone Hcl	Buspirone Hcl	37	11
Hydralazine Hcl	Hydralazine Hcl	36	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	36	13
Ezetimibe	Ezetimibe	35	suppressed
Nifedipine Er	Nifedipine	35	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Finasteride	Finasteride	34	suppressed
Mirtazapine	Mirtazapine	34	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	11
Oxycodone Hcl	Oxycodone Hcl	32	suppressed
Alprazolam	Alprazolam	31	suppressed
Farxiga	Dapagliflozin Propanediol	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Valsartan	Valsartan	31	11
Diclofenac Sodium	Diclofenac Sodium	29	12
Fenofibrate	Fenofibrate	28	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Myrbetriq	Mirabegron	28	suppressed
Naproxen	Naproxen	27	12
Pregabalin	Pregabalin	27	suppressed
Celecoxib	Celecoxib	26	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Clobetasol Propionate	Clobetasol Propionate	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Mounjaro	Tirzepatide	22	suppressed
True Comfort Pro Alcohol Pads	Alcohol Antiseptic Pads	22	suppressed
Clotrimazole	Clotrimazole	20	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Ondansetron Odt	Ondansetron	19	11
Azelastine Hcl	Azelastine Hcl	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Ammonium Lactate	Ammonium Lactate	17	suppressed
Insulin Aspart Flexpen	Insulin Aspart	17	suppressed
Naltrexone Hcl	Naltrexone Hcl	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Nateglinide	Nateglinide	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	14
Entresto	Sacubitril/Valsartan	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Nyamyc	Nystatin	15	suppressed
Prednisone	Prednisone	15	15
True Comfort Safety Pen Needle	Pen Needle, Diabetic, Safety	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Ursodiol	Ursodiol	14	suppressed
Cephalexin	Cephalexin	13	11
Diazepam	Diazepam	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Topiramate	Topiramate	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Estradiol	Estradiol	12	suppressed
Linzess	Linaclotide	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Mesalamine Er	Mesalamine	12	suppressed
Nitroglycerin	Nitroglycerin	12	11
Nurtec Odt	Rimegepant Sulfate	12	suppressed
Prolia	Denosumab	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	11
Klor-Con M20	Potassium Chloride	11	suppressed
Nystatin	Nystatin	11	suppressed
Ramipril	Ramipril	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error